首页> 外文期刊>American Journal of Dermatopathology >Benign atypical intravascular CD30(+) T-cell proliferation: a reactive condition mimicking intravascular lymphoma.
【24h】

Benign atypical intravascular CD30(+) T-cell proliferation: a reactive condition mimicking intravascular lymphoma.

机译:良性非典型血管内CD30(+)T细胞增殖:模仿血管内淋巴瘤的反应性疾病。

获取原文
获取原文并翻译 | 示例
           

摘要

CD30 is a transmembrane glycoprotein molecule usually expressed in activated B and T cells. Although it has been considered a reliable marker for CD30 lymphomas, reactive inflammatory disorders may contain a significant number of CD30 cells mimicking lymphoproliferative disorders clinically or histologically. Intravascular lymphoma is a rare variant of non-Hodgkin lymphoma that can involve the skin in 40% of the patients. The majority of cases show a B-cell phenotype, and only a minority of cases are of T-cell or NK-cell origin. Moreover, 2 aggressive cases of intravascular large T-cell lymphoma have been described with a CD30 phenotype. Herein, we report 2 patients with skin lesions showing an atypical intravascular CD30 T-cell proliferation. Both the patients did not present systemic disease and therefore exhibit a favorable outcome. To the best of our knowledge, this is the second report in the literature of a benign intravascular CD30 T-cell proliferation that represents an intriguing differential diagnosis for intravascular lymphoma.
机译:CD30是通常在活化的B细胞和T细胞中表达的跨膜糖蛋白分子。尽管已被认为是CD30淋巴瘤的可靠标志物,但反应性炎性疾病可能包含大量CD30细胞,在临床或组织学上可模拟淋巴增生性疾病。血管内淋巴瘤是非霍奇金淋巴瘤的罕见变体,可累及40%的患者皮肤。大多数病例显示B细胞表型,只有少数病例来自T细胞或NK细胞。而且,已经描述了2例具有CD30表型的血管内大T细胞淋巴瘤的侵袭性病例。本文中,我们报告了2例皮肤病变的患者,显示非典型的血管内CD30 T细胞增殖。两名患者均未出现全身性疾病,因此表现出良好的预后。据我们所知,这是良性血管内CD30 T细胞增殖文献的第二篇报道,代表了对血管内淋巴瘤的有趣的鉴别诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号